Optimizing the efficiency of therapeutic HIV vaccine trials: A case for CTN 173

Conclusions Randomized controlled trials such as CTN 173, with well-defined surrogate endpoints and frequent immunologic and virologic monitoring, are necessary to streamline the approach to effective vaccine discovery and to ensure patient safety.
Source: Trials in Vaccinology - Category: Infectious Diseases Source Type: research